[67Cu]Cu-EB-TATE

N/A

Report date: 2025/10/28 16:07:01
NME

Base Information

Drug Name[67Cu]Cu-EB-TATE
Drug Alias Name[67Cu]-EB-TATE
ClassificationRadiation-emitting products > Nuclides > Copper > 67CuRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radioactive therapeutic agent +[4
Mechanisms of ActionSomatostatin receptor 2 binders
TargetsSomatostatin receptor 2
Therapy Area/IndicationsNeuroendocrine Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Saskatchewan
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeuroendocrine Tumors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A